Stuart Poulton
EVP, Chief Development Officer at Karyopharm Therapeutics · 8 reported transactions in 1 company · latest trade Jul 28, 2026
Their trades
Sold | Jul 28, 2026 | Jul 28, 2026 close $7.09 → Oct 30, 2026 close $0.66. S&P 500 +2.0% over the same days. | ||
Sold | Mar 2, 2026 | Mar 2, 2026 close $9.59 → Oct 30, 2026 close $0.66. S&P 500 +10.1% over the same days. | ||
Sold | Feb 17, 2026 | Feb 17, 2026 close $9.40 → Oct 30, 2026 close $0.66. S&P 500 +10.7% over the same days. | ||
Sold | Sep 15, 2025 | Sep 15, 2025 close $6.26 → Oct 30, 2026 close $0.66. S&P 500 +14.3% over the same days. | ||
Sold | Jul 29, 2025 | Jul 29, 2025 close $4.13 → Oct 30, 2026 close $0.66. S&P 500 +19.0% over the same days. |
$1.3K
Jul 28, 2026 close $7.09 → Oct 30, 2026 close $0.66. S&P 500 +2.0% over the same days.
$48K
Mar 2, 2026 close $9.59 → Oct 30, 2026 close $0.66. S&P 500 +10.1% over the same days.
$3.3K
Feb 17, 2026 close $9.40 → Oct 30, 2026 close $0.66. S&P 500 +10.7% over the same days.
$2.6K
Sep 15, 2025 close $6.26 → Oct 30, 2026 close $0.66. S&P 500 +14.3% over the same days.
$834.67
Jul 29, 2025 close $4.13 → Oct 30, 2026 close $0.66. S&P 500 +19.0% over the same days.